Randomized Phase II Trial of Docetaxel plus Nivolumab or Docetaxel alone in patients with advanced non-squamous NSCLC and previous clinical benefit on treatment with single agent Nivolumab HCRN LUN15-233

  • Willis, Maurice, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date4/3/174/2/19